Category: Workers Comp

505 posts found

FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury

A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.

What will 2020 hold for marijuana acceptance, employee misclassification, formularies, and AI?

An analysis of 1.5 million claims found early physical therapy lowers odds of opioid use by 14%.

Testing positive for marijuana use could one day no longer prohibit employment.

With a flurry of opioid developments lately, what does the big picture look like?

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.

Does the active ingredient in magic mushrooms have a future in mental health?

Phase 3 studies are underway, and current research sees potential for MDMA in psychotherapy.

A recent meta-analysis of over 100 trials and studies found lavender to significantly reduce anxiety levels.

A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.

Understand how prices are set for medical equipment and services, and how to scrutinize those costs.

According to the CWCI, reduced opioid utilization from 2010-2017 saved $6.5 billion in California comp costs.

Beyond compensability, Minnesota considers rules for evaluation, treatment planning, acceptable psychotherapies, and more.

Workers’ comp publications cover Healthesystems content surrounding aging physicians, successful return-to-work programs, and more.

A previous gastrointestinal drug recall expands, while a new recall for an anxiety drug is issued.

Prev 1 2 3 4 5 … 24 25 26 27 28 … 30 31 32 33 34 Next